WPC
DGX icon

Wedmont Private Capital’s Quest Diagnostics DGX Stock Holding History

Wedmont Private Capital’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$647K Buy
3,120
+86
+3% +$16.9K 0.02% 478
2026
Q1 		$603K Buy
3,034
+319
+12% +$62K 0.02% 434
2025
Q4 		$484K Sell
2,715
-225
-8% -$41K 0.02% 490
2025
Q3 		$535K Buy
2,940
+337
+13% +$59.8K 0.02% 446
2025
Q2 		$452K Buy
2,603
+78
+3% +$13.5K 0.02% 456
2025
Q1 		$414K Buy
2,525
+381
+18% +$62.6K 0.02% 431
2024
Q4 		$325K Buy
2,144
+179
+9% +$27.8K 0.02% 513
2024
Q3 		$289K Buy
1,965
+114
+6% +$17K 0.02% 522
2024
Q2 		$267K Buy
+1,851
New +$253K 0.02% 533
2023
Q1 		– Sell
-1,536
Closed -$239K – 475
2022
Q4 		$239K Buy
+1,536
New +$221K 0.04% 389
2022
Q3 		– Sell
-1,880
Closed -$250K – 376
2022
Q2 		$250K Buy
+1,880
New +$256K 0.05% 277

Other funds holding DGX

AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
EB
Eastern Bank Boston, Massachusetts $6.53B AUM 30.05% 1-Year Est. Return
CPC
Cookson Peirce & Co Pittsburgh, Pennsylvania $3.04B AUM 94.11% 1-Year Est. Return
AIM
Achmea Investment Management Zeist, Netherlands $4B AUM 31.99% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
AAIS
ABN AMRO Investment Solutions Paris Cedex 008 $11.5B AUM 32.2% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
BCAM
Boston Common Asset Management Boston, Massachusetts $1.69B AUM 28.29% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Wedmont Private Capital's DGX Position: Q2 2026 in Review

Wedmont Private Capital increased its Quest Diagnostics (DGX) stake by 2.8% in Q2 2026, buying an estimated $16.9K and bringing the position to 3,120 shares worth $647K. The position accounts for 0.02% of the portfolio, ranked #478.

Wedmont Private Capital first reported a position in DGX in Q2 2022 and has held it in 11 quarters since. 287 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Wedmont Private Capital held 3,120 shares of Quest Diagnostics worth $647K as of Q2 2026.
  • Wedmont Private Capital bought 86 Quest Diagnostics shares in Q2 2026, an estimated $16.9K.
  • Quest Diagnostics made up 0.02% of Wedmont Private Capital's portfolio in Q2 2026, its #478 holding.
  • Wedmont Private Capital first reported a position in Quest Diagnostics in Q2 2022 and has held it in 11 quarters since.
  • 287 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Wedmont Private Capital's 13F filing for Q2 2026, filed 13 Jul 2026.